Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Clinical Practice
100%
Breast Cancer Survivors
100%
Neoadjuvant Endocrine Therapy
100%
Oncologists
33%
Modifiable Factors
16%
Negatively Associated
16%
Breast Cancer Patients
16%
Long-term Survival
16%
Early Years
16%
Inclusion Criteria
16%
MEDLINE
16%
One-form
16%
Working Diagnosis
16%
Clinical Efficacy
16%
PubMed
16%
Behavioral Intervention
16%
Multi-step Process
16%
Aromatase Inhibitors
16%
Follow-up Care
16%
CINAHL
16%
PsycINFO
16%
Extreme of Age
16%
Treatment Side Effects
16%
General Practitioners
16%
Non-persistence
16%
Nursing and Health Professions
Clinical Practice
100%
Breast Cancer
100%
Systematic Review
100%
Hormonal Therapy
100%
Prevalence
33%
Medline
33%
Oncologist
33%
Behavioral Intervention
16%
General Practitioner
16%
Patient Referral
16%
Side Effect
16%
Long Term Survival
16%
CINAHL
16%
Tamoxifen
16%
Hormone Receptor
16%
Aromatase Inhibitor
16%
PsycINFO
16%
Diseases
16%
Medicine and Dentistry
Breast Cancer
100%
Systematic Review
100%
Hormone Therapy
100%
Prevalence
33%
Oncologist
33%
Health Care Cost
16%
Side Effect
16%
Aromatase Inhibitor
16%
Long Term Survival
16%
Patient Referral
16%
Tamoxifen
16%
CYP2D6
16%
Hormone Receptor
16%
General Practitioner
16%
Diseases
16%